Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos

Toxicology and Applied Pharmacology

Volumn 152, Issue 2, 1998, Pages 388-396

  Barchowsky, Aaron ^a   Roussel, Robert R ^a   Krieser, Ronald J ^a   Mossman, Brooke T ^b   Treadwell, Melinda D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHRYSOTILE; CROCIDOLITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN; TRANSCRIPTION FACTOR; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; ASBESTOSIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPITHELIUM CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOMA; LUNG FIBROSIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0032190673     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8462     Document Type: Article

References (57)

1. Almenar-Queralt A., Duperray A., Miles L. A., Felez J., Altieri D. C. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am. J. Pathol. 147:1995;1278-1288.
2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Andreasen P. A., Kjoller L., Christensen L., Duffy M. J. The urokinase-type plasminogen activator system in cancer metastasis: A review. Int. J. Cancer. 72:1997;1-22.
4. Barchowsky A., Dudek E. J., Treadwell M. D., Wetterharn K. E. Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radical Biol. Med. 21:1996;783-790.
5. Barchowsky A., Lannon B. M., Elmore L. C., Treadwell M. D. Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos. Environ. Health Perspect. 105:1997;1131-1137.
6. Barchowsky A., Munro S. R., Morana S. J., Vincenti M. P., Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am. J. Physiol. 269:1995;L829-L836.
7. Barchowsky A., Tabrizi K., Kent R. S., Whorton A. R. Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells. J. Clin. Invest. 83:1989;1153-1159.
8. Bayraktutan U., Jones P. Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton. Exp. Cell Res. 221:1995;486-495.
9. Bianchi E., Ferrero E., Fazioli F., Mangili F., Wang J., Bender J. R., Blasi F., Pardi R. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J. Clin. Invest. 98:1996;1133-1141.
10. Blasi F. The urokinase receptor and cell migration. Semin. Thromb. Hemostasis. 22:1996;513-516.
11. Boylan A. M., Sanan D. A., Sheppard D., Broaddus V. C. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J. Clin. Invest. 96:1995;1987-2001.
12. Branchaud R. M., MacDonald J. L., Kane A. B. Induction of angiogenesis by intraperitoneal injection of asbestos fibers. FASEB J. 3:1989;1747-1752.
13. Callahan K. S., Griffith D. E., Garcia J. G. Asbestos exposure results in increased lung procoagulant activityin vivoin vitro. Chest. 98:1990;112-119.
14. Chang L. Y., Overby L. H., Brody A. R., Crapo J. D. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am. J. Pathol. 131:1988;156-170.
15. Collins T., Read M. A., Neish A. S., Whitley M. Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
16. Conese M., Blasi F. Urokinase/urokinase receptor system: Internalization/degradation of urokinase-serpin complexes: Mechanism and regulation. Biol. Chem. Hoppe-Seyler. 376:1995;143-155.
17. Crowley C. W., Cohen R. L., Lucas B. K., Liu G., Shuman M. A., Levinson A. D. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA. 90:1993;5021-5025.
18. Eddy A. A., Giachelli C. M. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int. 47:1995;1546-1557.
19. Gross T. J., Cobb S. M., Gruenert D. C., Peterson M. W. Asbestos exposure increases human bronchial epithelial cell fibrinolytic activity. Am. J. Physiol. 264:1993;L276-L283.
20. Guerrini L., Casalino L., Corti A., Blasi F. NF-kappa B-mediated regulation of urokinase gene expression by PMA and TNF-alpha in human A549 cells. FEBS Lett. 393:1996;69-73.
21. Gyetko M. R., Sitrin R. G., Fuller J. A., Todd R. F., Petty H., Standiford T. J. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leukocyte Biol. 58:1995;533-538.
22. Hamilton J., Vassalli J.-D., Reich E. Macrophage plasminogen activator: Induction by asbestos is blocked by anti-inflammatory steroids. J. Exp. Med. 144:1976;1689-1694.
23. Hamilton J. A. Suppression of the neutral protease activity of macrophages treated with asbestosin vitro. Environ. Health Perspect. 51:1983a;103-108.
24. Hamilton J. A. Asbestos fibers, plasma and inflammation. Environ. Health Perspect. 51:1983b;281-285.
25. Hauser I. A., Setter E., Bell L., Madri J. A. Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cellsin vitro. Am. J. Pathol. 143:1993;173-180.
26. Hesterberg T. W., Miller W. C., McConnell E. E., Chevalier J., Hadley J. G., Bernstein D. M., Thevenaz P., Anderson R. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundam. Appl. Toxicol. 20:1993;464-476.
27. Hoyle G. W., Brody A. R. Gene expression in rodent model of environmental lung disease. Ann. NY Acad. Sci. 796:1996;162-172.
28. Irigoyen J. P., Besser D., Nagamine Y. Cytoskeleton reorginization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway. J. Biol. Chem. 272:1997;1904-1909.
29. Janssen Y. M., Barchowsky A., Treadwell M., Driscoll K. E., Mossman B. T. Asbestos induces nuclear factor kappa B (NF-κB) DNA-binding activity and NF-κB-dependent gene expression in tracheal epithelial cells. Proc. Natl. Acad. Sci. USA. 92:1995;8458-8462.
30. Janssen Y. M., Driscoll K. E., Howard B., Quinlan T. R., Treadwell M., Barchowsky A., Mossman B. T. Asbestos causes translocation of p65 protein and increases NF-κB DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am. J. Pathol. 151:1997;389-401.
31. Kilgore K. S., Schmid E., Shanley T. P., Flory C. M., Maheswari V., Tramontini N. L., Cohen H., Ward P. A., Friedl H. P., Warren J. S. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am. J. Pathol. 150:1997;2019-2031.
32. Lu H., Mabilat C., Yeh P., Guitton J. D., Li H., Pouchelet M., Shoevaert D., Legrand Y., Soria J., Soria C. Blockage of urokinase receptor reducesin vitro. FEBS Lett. 380:1996;21-24.
33. McGavran P. D., Moore L. B., Brody A. R. Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats. Am. J. Pathol. 136:1990;695-705.
34. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:1993;161-195.
35. Mossman B. T., Faux S., Janssen Y., Jimenez L. A., Timblin C., Zanella C., Goldberg J., Walsh E., Barchowsky A., Driscoll K. Cell signaling pathways elicited by asbestos. Environ. Health Perspect. 105:1997;1121-1125.
36. Mossman B. T., Gee J. B. L. Pulmonary reactions and mechanisms of toxicity of inhaled fibers. Toxicology of the Lung. 1993;Raven Press, New York. p. 371-387.
37. Mossman B. T., Kamp D. W., Weitzman S. A. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest. 14:1996;466-480.
38. Novak U., Cocks B. G., Hamilton J. A. A labile repressor acts through the NFκB-like binding sites of the human urokinase gene. Nucleic Acids Res. 19:1991;3389-3393.
39. Raghow R. Role of transforming growth factor-beta in repair and fibrosis. Chest. 99:1991;61S-65S.
40. Rao N. K., Shi G. P., Chapman H. A. Urokinase receptor is a multifunctional protein: Influence of receptor occupancy on macrophage gene expression. J. Clin. Invest. 96:1995;465-474.
41. Reuning U., Wilhelm O., Nishiguchi T., Guerrini L., Blasi F., Graeff H., Schmitt M. Inhibition of NF-κ B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1. Nucleic Acids Res. 23:1995;3887-3893.
42. Rom W. N., Travis W. D., Brody A. R. Cellular and molecular basis of the asbestos-related diseases. Am. Rev. Respir. Dis. 143:1991;408-422.
43. Sappino A. P., Huarte J., Vassalli J. D., Belin D. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest. 87:1991;962-970.
44. Shetty S., Kumar A., Idell S. Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17:1997;1075-1083.
45. Shetty S., Kumar A., Johnson A., Pueblitz S., Idell S. Urokinase receptor in human malignant mesothelioma cells: Role in tumor cell mitogenesis and proteolysis. Am. J. Physiol. 268:1995;L972-L982.
46. Shetty S., Kumar A., Johnson A. R., Pueblitz S., Holiday D., Raghu G., Idell S. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am. J. Respir. Cell Mol. Biol. 15:1996;78-87.
47. Simeonova P. P., Luster M. I. Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Am. J. Respir. Cell Mol. Biol. 15:1996;787-795.
48. Sitrin R. G., Todd R. F. I., Petty H. R., Brock T. G., Shollenberger S. B., Albrecht E., Gyetko M. R. The urokinase receptor (CD87) facilitates CD11/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97:1996;1942-1951.
49. Soravia E., Grebe A., De Luca P., Helin K., Suh T. T., Degen J. L., Blasi F. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood. 86:1995;624-635.
50. Spiers E. M., Lazarus G. S., Lyons-Giordano B. Expression of plasminogen activator enzymes in psoriatic epidermis. J. Invest. Dermatol. 102:1994;333-338.
51. Stancovski I., Baltimore D. NF-κB activation: The IκB kinase revealed. Cell. 91:1997;299-302.
52. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E. J. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441.
53. Treadwell M. D., Mossman B. T., Barchowsky A. Induction of neutrophil adherence to endothelial cells following exposure to asbestos. Toxicol. Appl. Pharmacol. 139:1996;62-70.
54. Vassalli J.-D., Sappino A. P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067-1072.
55. Washington R., Burton J., Todd R. F., Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann. Neurol. 35:1994;89-97.
56. Wei Y., Waltz D. A., Rao N., Drummond R. J., Rosenberg S., Chapman H. A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:1994;32380-32388.
57. Zanella C. L., Posada J., Tritton T. R., Mossman B. T. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56:1996;5334-5338.